Supply of Bacitracin Ointment (Pharmaceutical Manufacturing)

The contract pertains to the manufacture and supply of Bacitracin Ointment specifically for military medical use, with strict adherence to designated National Drug Codes and packaging standards mandated by the Department of Defense. The work is being executed as a subcontract under the Defense Logistics Agency, with the North American Industry Classification System code 325412 indicating pharmaceutical and biological product manufacturing as the primary activity. Production must meet all federal and military specifications for sterility, stability, labeling, and distribution to ensure compatibility with existing military medical supply protocols and logistics systems. The contract is scheduled for performance following a posting date of July 21, 2026, and the place of performance remains unspecified, suggesting that manufacturing may occur at multiple authorized facilities as long as final delivery complies with defense logistics requirements. The ointment will be distributed through the Department of Defense’s medical supply chain, supporting frontline medical units and contingency operations. All packaging and labeling must align with standardized military documentation and identification systems to ensure traceability, inventory accuracy, and operational readiness in field environments.